Humoral Hypercalcemia of Malignancy, Hyperparathyroidism, Osteoporosis
Conditions
Keywords
Endocrine System Diseases, MusculoSkeletal System Diseases, Hormones, Malignancy, Postmenopausal Women, Bone metabolism
Brief summary
This is a dose escalation study to determine the maximum tolerable dose of Parathyroid Hormone-related Protein, PTHrP, that can be given safely over one week. The investigators plan to infuse low doses of intravenous PTHrP to determine if it leads to a sustained and progressive suppression of bone formation as occurs in humoral hypercalcemia of malignancy (HHM) or an increase in bone formation as occurs in hyperparathyroidism (HPT). Additionally, the investigators will assess the direct influence of PTHrp on markers of bone turnover, and plasma 1,25 (OH)2 vitamin D regulation in healthy human volunteers.
Detailed description
During this research the investigators administer PTHrP to healthy young volunteers in a controlled, continuous intravenous manner. As research subjects complete the week-long study without adverse effects, the dose of PThrP will be increased in later subjects. In the event of a significant adverse effect, immediate action will be taken to reverse it. The investigators want to estimate the effect of a sustainable level of mild hypercalcemia achieved by a week-long intravenous infusion of PTHrP has on vitamin D metabolism, markers of bone turnover and fractional excretion of calcium.
Interventions
IND # 49,175
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy caucasian subjects of both sexes between the ages of 24-35 years, who are able to spend one week on the Clinical & Translational Research Center at the University of Pittsburgh Medical Center (UPMC) Montefiore
Exclusion criteria
* Pregnancy * Any cardiac, renal, pulmonary, endocrine, musculoskeletal, hepatic, hematological, malignant or rheumatologic diseases * Body mass index great than 30 * Anemia * Significant alcohol or drug abuse * Baseline hypotension or hypertension * Abnormal screening labs * Use of certain chronic medications excluding oral contraceptives * Receiving an investigational drug in the last 90 days * Previously receiving PTH or PTHrP * African-American race
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dose Limiting Toxicity (DLT) | 12 hours after the infusion was started then q 8 hours for 7 days | DLT was defined as achieving one major criterion or two minor criteria rated at ≥ 2 on a scale of 0-5. The major criteria were defined as symptomatic orthostatic hypotension (systolic BP fall \>30 mm/hg), tachycardia (pulse \> 120), hypertension (systolic BP \>160 mm/hg on 2 occasions), hypercalcemia (serum calcium ≥ 12 mg/dl), and hypophosphatemia (serum phosphorous \< 1.5 mg/dl). Minor criteria included symptoms such as flushing, nausea, abdominal or muscle cramps, dizziness, lightheadedness, palpitations, etc. |
| Total Serum Calcium | 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete | mg/dl |
| Ionized Serum Calcium | 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete | mg/dl |
| Serum Phosphorous | 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete | mg/dl |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Baseline, Daily, and 1 week follow-up | % change from baseline |
| Amino-terminal Peptides of Procollagen 1 (P1NP) | Baseline, Daily, and 1 week follow-up | % change from baseline |
| 1,25 Vitamin D | Baseline and Daily through day 8 then at follow-up visit | pg/ml |
| Parathyroid Hormone (1-84) | Baseline and Daily | pg/ml |
| Fractional Excretion of Calcium | daily | % calculated from daily second morning void |
| Bone Specific Alkaline Phosphatase (BSAP) | Baseline, Daily, and 1 week follow-up | % change from baseline |
| 24 Hour Urine Calcium | 24 hours | mg/gm creatinine collected on day 7 of PTHrP infusion |
| Tubular Maximum of Phosphorous (TmP/GFR) | daily | mg/dl calculated from daily second morning void |
| Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Baseline, Daily, and 1 week follow-up | % change from baseline |
Countries
United States
Participant flow
Recruitment details
24 subjects were screened and 14 were randomized in the study. Data from 2 subjects was not included in the analysis as there were not enough subjects in that group for analysis. 12 subjects were analyzed.
Participants by arm
| Arm | Count |
|---|---|
| Group 1 PTHrP(1-36) 2 picomoles/kg/hr for one week. | 3 |
| Group 2 PTHrP(1-36) 4 picomoles/kg/hr for one week. | 6 |
| Group 3 PTHrP(1-36) 5 picomoles/kg/hr for one week. | 3 |
| Group 4 PTHrP(1-36) 6 picomoles/kg/hr for one week. | 2 |
| Total | 14 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Overall Study | Adverse Event | 0 | 0 | 0 | 1 |
Baseline characteristics
| Characteristic | Group 1 | Group 2 | Group 3 | Group 4 | Total |
|---|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 3 Participants | 6 Participants | 3 Participants | 2 Participants | 14 Participants |
| Region of Enrollment United States | 3 participants | 6 participants | 3 participants | 2 participants | 14 participants |
| Sex: Female, Male Female | 2 Participants | 3 Participants | 2 Participants | 0 Participants | 7 Participants |
| Sex: Female, Male Male | 1 Participants | 3 Participants | 1 Participants | 2 Participants | 7 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 3 | 0 / 6 | 1 / 3 | 2 / 2 |
| serious Total, serious adverse events | 0 / 3 | 0 / 6 | 0 / 3 | 0 / 2 |
Outcome results
Dose Limiting Toxicity (DLT)
DLT was defined as achieving one major criterion or two minor criteria rated at ≥ 2 on a scale of 0-5. The major criteria were defined as symptomatic orthostatic hypotension (systolic BP fall \>30 mm/hg), tachycardia (pulse \> 120), hypertension (systolic BP \>160 mm/hg on 2 occasions), hypercalcemia (serum calcium ≥ 12 mg/dl), and hypophosphatemia (serum phosphorous \< 1.5 mg/dl). Minor criteria included symptoms such as flushing, nausea, abdominal or muscle cramps, dizziness, lightheadedness, palpitations, etc.
Time frame: 12 hours after the infusion was started then q 8 hours for 7 days
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Group 1 | Dose Limiting Toxicity (DLT) | 0 participants |
| Group 2 | Dose Limiting Toxicity (DLT) | 0 participants |
| Group 3 | Dose Limiting Toxicity (DLT) | 2 participants |
| Group 4 | Dose Limiting Toxicity (DLT) | 2 participants |
Ionized Serum Calcium
mg/dl
Time frame: 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Ionized Serum Calcium | 3P DAY 5 | 4.61 mg/dl | Standard Error 0.2 |
| Group 1 | Ionized Serum Calcium | 11P DAY 2 | 4.48 mg/dl | Standard Error 0.08 |
| Group 1 | Ionized Serum Calcium | 3P DAY 7 | 4.84 mg/dl | Standard Error 0.16 |
| Group 1 | Ionized Serum Calcium | 7A DAY 5 | 4.71 mg/dl | Standard Error 0.07 |
| Group 1 | Ionized Serum Calcium | 7A DAY 3 | 4.77 mg/dl | Standard Error 0.15 |
| Group 1 | Ionized Serum Calcium | FOLLOW-UP | 4.68 mg/dl | Standard Error 0.08 |
| Group 1 | Ionized Serum Calcium | 11P DAY 4 | 4.47 mg/dl | Standard Error 0.07 |
| Group 1 | Ionized Serum Calcium | 3P DAY 3 | 4.73 mg/dl | Standard Error 0.11 |
| Group 1 | Ionized Serum Calcium | 3P DAY 6 | 4.72 mg/dl | Standard Error 0.13 |
| Group 1 | Ionized Serum Calcium | 3P DAY 4 | 4.45 mg/dl | Standard Error 0.16 |
| Group 1 | Ionized Serum Calcium | 11P DAY 3 | 4.41 mg/dl | Standard Error 0.15 |
| Group 1 | Ionized Serum Calcium | baseline | 4.79 mg/dl | Standard Error 0.03 |
| Group 1 | Ionized Serum Calcium | 11P DAY 7 | 4.56 mg/dl | Standard Error 0.12 |
| Group 1 | Ionized Serum Calcium | 7A DAY 8 | 5.00 mg/dl | Standard Error 0.11 |
| Group 1 | Ionized Serum Calcium | 7A DAY 7 | 4.55 mg/dl | Standard Error 0.22 |
| Group 1 | Ionized Serum Calcium | 7A DAY 6 | 4.63 mg/dl | Standard Error 0.03 |
| Group 1 | Ionized Serum Calcium | 7A DAY 4 | 4.75 mg/dl | Standard Error 0.14 |
| Group 1 | Ionized Serum Calcium | 7A DAY 2 | 4.77 mg/dl | Standard Error 0.07 |
| Group 1 | Ionized Serum Calcium | 11P DAY 1 | 4.51 mg/dl | Standard Error 0.05 |
| Group 1 | Ionized Serum Calcium | 11P DAY 5 | 4.60 mg/dl | Standard Error 0.13 |
| Group 1 | Ionized Serum Calcium | 3P DAY 2 | 4.52 mg/dl | Standard Error 0.02 |
| Group 1 | Ionized Serum Calcium | 11P DAY 6 | 4.32 mg/dl | Standard Error 0.06 |
| Group 2 | Ionized Serum Calcium | 7A DAY 4 | 4.90 mg/dl | Standard Error 0.13 |
| Group 2 | Ionized Serum Calcium | baseline | 4.72 mg/dl | Standard Error 0.08 |
| Group 2 | Ionized Serum Calcium | 11P DAY 1 | 4.77 mg/dl | Standard Error 0.08 |
| Group 2 | Ionized Serum Calcium | 7A DAY 7 | 5.01 mg/dl | Standard Error 0.09 |
| Group 2 | Ionized Serum Calcium | 3P DAY 7 | 5.04 mg/dl | Standard Error 0.17 |
| Group 2 | Ionized Serum Calcium | 11P DAY 7 | 4.87 mg/dl | Standard Error 0.19 |
| Group 2 | Ionized Serum Calcium | 11P DAY 3 | 4.58 mg/dl | Standard Error 0.15 |
| Group 2 | Ionized Serum Calcium | 7A DAY 2 | 4.98 mg/dl | Standard Error 0.1 |
| Group 2 | Ionized Serum Calcium | 3P DAY 2 | 4.99 mg/dl | Standard Error 0.06 |
| Group 2 | Ionized Serum Calcium | 11P DAY 2 | 5.04 mg/dl | Standard Error 0.07 |
| Group 2 | Ionized Serum Calcium | 7A DAY 3 | 5.31 mg/dl | Standard Error 0.08 |
| Group 2 | Ionized Serum Calcium | 3P DAY 3 | 4.99 mg/dl | Standard Error 0.1 |
| Group 2 | Ionized Serum Calcium | 3P DAY 4 | 4.68 mg/dl | Standard Error 0.14 |
| Group 2 | Ionized Serum Calcium | 11P DAY 4 | 4.46 mg/dl | Standard Error 0.12 |
| Group 2 | Ionized Serum Calcium | 7A DAY 5 | 4.82 mg/dl | Standard Error 0.09 |
| Group 2 | Ionized Serum Calcium | 3P DAY 5 | 4.67 mg/dl | Standard Error 0.12 |
| Group 2 | Ionized Serum Calcium | 11P DAY 5 | 4.58 mg/dl | Standard Error 0.07 |
| Group 2 | Ionized Serum Calcium | 7A DAY 6 | 4.77 mg/dl | Standard Error 0.1 |
| Group 2 | Ionized Serum Calcium | 3P DAY 6 | 4.83 mg/dl | Standard Error 0.07 |
| Group 2 | Ionized Serum Calcium | 11P DAY 6 | 4.72 mg/dl | Standard Error 0.09 |
| Group 2 | Ionized Serum Calcium | 7A DAY 8 | 5.43 mg/dl | Standard Error 0.18 |
| Group 2 | Ionized Serum Calcium | FOLLOW-UP | 4.83 mg/dl | Standard Error 0.05 |
| Group 3 | Ionized Serum Calcium | 3P DAY 2 | 5.07 mg/dl | Standard Error 0.06 |
| Group 3 | Ionized Serum Calcium | 11P DAY 7 | 5.24 mg/dl | Standard Error 0.02 |
| Group 3 | Ionized Serum Calcium | 3P DAY 5 | 4.87 mg/dl | Standard Error 0.4 |
| Group 3 | Ionized Serum Calcium | 7A DAY 2 | 5.07 mg/dl | Standard Error 0.07 |
| Group 3 | Ionized Serum Calcium | 11P DAY 1 | 4.75 mg/dl | Standard Error 0.04 |
| Group 3 | Ionized Serum Calcium | 11P DAY 5 | 4.79 mg/dl | Standard Error 0.09 |
| Group 3 | Ionized Serum Calcium | 11P DAY 3 | 4.83 mg/dl | Standard Error 0.14 |
| Group 3 | Ionized Serum Calcium | FOLLOW-UP | 4.80 mg/dl | Standard Error 0.06 |
| Group 3 | Ionized Serum Calcium | 7A DAY 6 | 5.25 mg/dl | Standard Error 0.09 |
| Group 3 | Ionized Serum Calcium | 3P DAY 7 | 5.25 mg/dl | Standard Error 0.31 |
| Group 3 | Ionized Serum Calcium | 7A DAY 8 | 5.69 mg/dl | Standard Error 0.1 |
| Group 3 | Ionized Serum Calcium | 3P DAY 6 | 5.35 mg/dl | Standard Error 0.03 |
| Group 3 | Ionized Serum Calcium | 7A DAY 4 | 5.11 mg/dl | Standard Error 0.09 |
| Group 3 | Ionized Serum Calcium | 3P DAY 3 | 4.91 mg/dl | Standard Error 0.16 |
| Group 3 | Ionized Serum Calcium | 7A DAY 7 | 5.55 mg/dl | Standard Error 0.27 |
| Group 3 | Ionized Serum Calcium | 3P DAY 4 | 4.72 mg/dl | Standard Error 0.17 |
| Group 3 | Ionized Serum Calcium | 7A DAY 3 | 5.25 mg/dl | Standard Error 0.13 |
| Group 3 | Ionized Serum Calcium | baseline | 4.55 mg/dl | Standard Error 0.15 |
| Group 3 | Ionized Serum Calcium | 11P DAY 4 | 4.69 mg/dl | Standard Error 0.06 |
| Group 3 | Ionized Serum Calcium | 11P DAY 2 | 4.84 mg/dl | Standard Error 0 |
| Group 3 | Ionized Serum Calcium | 11P DAY 6 | 5.19 mg/dl | Standard Error 0.21 |
| Group 3 | Ionized Serum Calcium | 7A DAY 5 | 4.97 mg/dl | Standard Error 0.12 |
Serum Phosphorous
mg/dl
Time frame: 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Serum Phosphorous | 11P DAY 2 | 4.13 mg/dl | Standard Error 0.29 |
| Group 1 | Serum Phosphorous | 11P DAY 5 | 3.93 mg/dl | Standard Error 0.23 |
| Group 1 | Serum Phosphorous | 11P DAY 3 | 4.03 mg/dl | Standard Error 0.26 |
| Group 1 | Serum Phosphorous | 11P DAY 1 | 3.87 mg/dl | Standard Error 0.26 |
| Group 1 | Serum Phosphorous | 3P DAY 5 | 3.57 mg/dl | Standard Error 0.29 |
| Group 1 | Serum Phosphorous | 7A DAY 4 | 4.07 mg/dl | Standard Error 0.22 |
| Group 1 | Serum Phosphorous | 3P DAY 7 | 4.07 mg/dl | Standard Error 0.09 |
| Group 1 | Serum Phosphorous | 7A DAY 5 | 3.87 mg/dl | Standard Error 0.19 |
| Group 1 | Serum Phosphorous | 3P DAY 4 | 3.90 mg/dl | Standard Error 0.1 |
| Group 1 | Serum Phosphorous | 7A DAY 3 | 3.90 mg/dl | Standard Error 0.26 |
| Group 1 | Serum Phosphorous | 11P DAY 4 | 3.67 mg/dl | Standard Error 0.28 |
| Group 1 | Serum Phosphorous | FOLLOW-UP | 3.57 mg/dl | Standard Error 0.38 |
| Group 1 | Serum Phosphorous | 11P DAY 6 | 3.93 mg/dl | Standard Error 0.18 |
| Group 1 | Serum Phosphorous | 7A DAY 7 | 4.30 mg/dl | Standard Error 0.1 |
| Group 1 | Serum Phosphorous | 7A DAY 8 | 4.43 mg/dl | Standard Error 0.15 |
| Group 1 | Serum Phosphorous | 3P DAY 6 | 3.67 mg/dl | Standard Error 0.03 |
| Group 1 | Serum Phosphorous | baseline | 3.55 mg/dl | Standard Error 0.15 |
| Group 1 | Serum Phosphorous | 7A DAY 2 | 4.07 mg/dl | Standard Error 0.15 |
| Group 1 | Serum Phosphorous | 7A DAY 6 | 4.00 mg/dl | Standard Error 0.06 |
| Group 1 | Serum Phosphorous | 3P DAY 2 | 3.63 mg/dl | Standard Error 0.33 |
| Group 1 | Serum Phosphorous | 11P DAY 7 | 4.20 mg/dl | Standard Error 0.26 |
| Group 1 | Serum Phosphorous | 3P DAY 3 | 3.53 mg/dl | Standard Error 0.24 |
| Group 2 | Serum Phosphorous | 3P DAY 6 | 3.80 mg/dl | Standard Error 0.14 |
| Group 2 | Serum Phosphorous | 11P DAY 1 | 3.90 mg/dl | Standard Error 0.16 |
| Group 2 | Serum Phosphorous | 11P DAY 2 | 3.52 mg/dl | Standard Error 0.19 |
| Group 2 | Serum Phosphorous | 7A DAY 3 | 3.77 mg/dl | Standard Error 0.19 |
| Group 2 | Serum Phosphorous | 7A DAY 7 | 4.28 mg/dl | Standard Error 0.12 |
| Group 2 | Serum Phosphorous | 7A DAY 2 | 4.20 mg/dl | Standard Error 0.15 |
| Group 2 | Serum Phosphorous | 3P DAY 2 | 3.50 mg/dl | Standard Error 0.23 |
| Group 2 | Serum Phosphorous | 3P DAY 3 | 3.53 mg/dl | Standard Error 0.18 |
| Group 2 | Serum Phosphorous | 11P DAY 3 | 3.58 mg/dl | Standard Error 0.17 |
| Group 2 | Serum Phosphorous | 7A DAY 4 | 3.90 mg/dl | Standard Error 0.13 |
| Group 2 | Serum Phosphorous | 3P DAY 4 | 3.37 mg/dl | Standard Error 0.2 |
| Group 2 | Serum Phosphorous | 11P DAY 4 | 3.48 mg/dl | Standard Error 0.14 |
| Group 2 | Serum Phosphorous | 7A DAY 5 | 4.02 mg/dl | Standard Error 0.14 |
| Group 2 | Serum Phosphorous | 3P DAY 5 | 3.35 mg/dl | Standard Error 0.2 |
| Group 2 | Serum Phosphorous | 11P DAY 5 | 3.45 mg/dl | Standard Error 0.2 |
| Group 2 | Serum Phosphorous | 7A DAY 6 | 4.00 mg/dl | Standard Error 0.1 |
| Group 2 | Serum Phosphorous | baseline | 3.63 mg/dl | Standard Error 0.14 |
| Group 2 | Serum Phosphorous | 11P DAY 6 | 3.90 mg/dl | Standard Error 0.1 |
| Group 2 | Serum Phosphorous | 3P DAY 7 | 3.62 mg/dl | Standard Error 0.2 |
| Group 2 | Serum Phosphorous | 11P DAY 7 | 3.62 mg/dl | Standard Error 0.19 |
| Group 2 | Serum Phosphorous | 7A DAY 8 | 4.10 mg/dl | Standard Error 0.1 |
| Group 2 | Serum Phosphorous | FOLLOW-UP | 3.48 mg/dl | Standard Error 0.26 |
| Group 3 | Serum Phosphorous | 11P DAY 5 | 3.87 mg/dl | Standard Error 0.32 |
| Group 3 | Serum Phosphorous | 7A DAY 2 | 3.63 mg/dl | Standard Error 0.44 |
| Group 3 | Serum Phosphorous | 11P DAY 7 | 3.60 mg/dl | Standard Error 0.3 |
| Group 3 | Serum Phosphorous | 7A DAY 6 | 3.63 mg/dl | Standard Error 0.35 |
| Group 3 | Serum Phosphorous | 7A DAY 7 | 3.73 mg/dl | Standard Error 0.38 |
| Group 3 | Serum Phosphorous | 11P DAY 1 | 4.03 mg/dl | Standard Error 0.12 |
| Group 3 | Serum Phosphorous | 3P DAY 6 | 3.73 mg/dl | Standard Error 0.19 |
| Group 3 | Serum Phosphorous | 7A DAY 3 | 3.43 mg/dl | Standard Error 0.39 |
| Group 3 | Serum Phosphorous | FOLLOW-UP | 3.87 mg/dl | Standard Error 0.09 |
| Group 3 | Serum Phosphorous | 11P DAY 6 | 3.93 mg/dl | Standard Error 0.09 |
| Group 3 | Serum Phosphorous | 11P DAY 2 | 3.63 mg/dl | Standard Error 0.19 |
| Group 3 | Serum Phosphorous | 3P DAY 4 | 3.33 mg/dl | Standard Error 0.32 |
| Group 3 | Serum Phosphorous | 7A DAY 8 | 3.40 mg/dl | Standard Error 0.23 |
| Group 3 | Serum Phosphorous | 11P DAY 4 | 3.63 mg/dl | Standard Error 0.27 |
| Group 3 | Serum Phosphorous | 7A DAY 4 | 3.30 mg/dl | Standard Error 0.4 |
| Group 3 | Serum Phosphorous | 3P DAY 7 | 3.50 mg/dl | Standard Error 0.2 |
| Group 3 | Serum Phosphorous | 7A DAY 5 | 3.20 mg/dl | Standard Error 0.3 |
| Group 3 | Serum Phosphorous | 11P DAY 3 | 3.70 mg/dl | Standard Error 0.15 |
| Group 3 | Serum Phosphorous | 3P DAY 2 | 3.70 mg/dl | Standard Error 0.2 |
| Group 3 | Serum Phosphorous | 3P DAY 5 | 3.10 mg/dl | Standard Error 0.21 |
| Group 3 | Serum Phosphorous | 3P DAY 3 | 3.60 mg/dl | Standard Error 0.23 |
| Group 3 | Serum Phosphorous | baseline | 3.55 mg/dl | Standard Error 0.45 |
Total Serum Calcium
mg/dl
Time frame: 12 hours after the infusion was started then q 8 hours for 7 days, Follow-up 1 week after infusion complete
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Total Serum Calcium | 3P DAY 5 | 9.50 mg/dl | Standard Error 0.15 |
| Group 1 | Total Serum Calcium | 11P DAY 2 | 9.67 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | 3P DAY 2 | 9.57 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | 7A DAY 5 | 9.30 mg/dl | Standard Error 0.12 |
| Group 1 | Total Serum Calcium | 7A DAY 3 | 9.6 mg/dl | Standard Error 0.1 |
| Group 1 | Total Serum Calcium | 3P DAY 7 | 9.70 mg/dl | Standard Error 0.15 |
| Group 1 | Total Serum Calcium | 11P DAY 4 | 9.37 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | 3P DAY 3 | 9.73 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | baseline | 9.37 mg/dl | Standard Error 0.07 |
| Group 1 | Total Serum Calcium | 3P DAY 4 | 9.40 mg/dl | Standard Error 0.17 |
| Group 1 | Total Serum Calcium | 11P DAY 3 | 9.40 mg/dl | Standard Error 0.17 |
| Group 1 | Total Serum Calcium | 11P DAY 7 | 9.60 mg/dl | Standard Error 0.15 |
| Group 1 | Total Serum Calcium | 7A DAY 4 | 9.47 mg/dl | Standard Error 0.03 |
| Group 1 | Total Serum Calcium | 7A DAY 7 | 9.40 mg/dl | Standard Error 0.1 |
| Group 1 | Total Serum Calcium | 3P DAY 6 | 9.43 mg/dl | Standard Error 0.15 |
| Group 1 | Total Serum Calcium | 7A DAY 8 | 9.83 mg/dl | Standard Error 0.13 |
| Group 1 | Total Serum Calcium | 7A DAY 2 | 9.4 mg/dl | Standard Error 0.17 |
| Group 1 | Total Serum Calcium | 7A DAY 6 | 9.57 mg/dl | Standard Error 0.07 |
| Group 1 | Total Serum Calcium | FOLLOW-UP | 9.33 mg/dl | Standard Error 0.07 |
| Group 1 | Total Serum Calcium | 11P DAY 1 | 9.67 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | 11P DAY 5 | 9.43 mg/dl | Standard Error 0.09 |
| Group 1 | Total Serum Calcium | 11P DAY 6 | 9.43 mg/dl | Standard Error 0.13 |
| Group 2 | Total Serum Calcium | 3P DAY 6 | 10.08 mg/dl | Standard Error 0.12 |
| Group 2 | Total Serum Calcium | baseline | 9.58 mg/dl | Standard Error 0.12 |
| Group 2 | Total Serum Calcium | 11P DAY 1 | 9.80 mg/dl | Standard Error 0.16 |
| Group 2 | Total Serum Calcium | 7A DAY 2 | 10.05 mg/dl | Standard Error 0.19 |
| Group 2 | Total Serum Calcium | 3P DAY 7 | 10.22 mg/dl | Standard Error 0.32 |
| Group 2 | Total Serum Calcium | 11P DAY 7 | 10.27 mg/dl | Standard Error 0.28 |
| Group 2 | Total Serum Calcium | 7A DAY 8 | 10.67 mg/dl | Standard Error 0.4 |
| Group 2 | Total Serum Calcium | FOLLOW-UP | 9.80 mg/dl | Standard Error 0.12 |
| Group 2 | Total Serum Calcium | 3P DAY 2 | 10.28 mg/dl | Standard Error 0.14 |
| Group 2 | Total Serum Calcium | 11P DAY 2 | 10.32 mg/dl | Standard Error 0.14 |
| Group 2 | Total Serum Calcium | 7A DAY 3 | 10.40 mg/dl | Standard Error 0.18 |
| Group 2 | Total Serum Calcium | 3P DAY 3 | 10.42 mg/dl | Standard Error 0.14 |
| Group 2 | Total Serum Calcium | 11P DAY 3 | 9.73 mg/dl | Standard Error 0.1 |
| Group 2 | Total Serum Calcium | 7A DAY 4 | 10.00 mg/dl | Standard Error 0.24 |
| Group 2 | Total Serum Calcium | 3P DAY 4 | 9.92 mg/dl | Standard Error 0.21 |
| Group 2 | Total Serum Calcium | 11P DAY 4 | 9.48 mg/dl | Standard Error 0.11 |
| Group 2 | Total Serum Calcium | 7A DAY 5 | 9.62 mg/dl | Standard Error 0.12 |
| Group 2 | Total Serum Calcium | 3P DAY 5 | 9.83 mg/dl | Standard Error 0.2 |
| Group 2 | Total Serum Calcium | 11P DAY 5 | 9.45 mg/dl | Standard Error 0.13 |
| Group 2 | Total Serum Calcium | 7A DAY 6 | 9.83 mg/dl | Standard Error 0.2 |
| Group 2 | Total Serum Calcium | 11P DAY 6 | 9.67 mg/dl | Standard Error 0.21 |
| Group 2 | Total Serum Calcium | 7A DAY 7 | 10.13 mg/dl | Standard Error 0.28 |
| Group 3 | Total Serum Calcium | 11P DAY 2 | 10.23 mg/dl | Standard Error 0.26 |
| Group 3 | Total Serum Calcium | 7A DAY 7 | 10.90 mg/dl | Standard Error 0.46 |
| Group 3 | Total Serum Calcium | 7A DAY 5 | 10.53 mg/dl | Standard Error 0.15 |
| Group 3 | Total Serum Calcium | 3P DAY 2 | 10.47 mg/dl | Standard Error 0.3 |
| Group 3 | Total Serum Calcium | 11P DAY 6 | 10.43 mg/dl | Standard Error 0.47 |
| Group 3 | Total Serum Calcium | 3P DAY 5 | 10.27 mg/dl | Standard Error 0.44 |
| Group 3 | Total Serum Calcium | FOLLOW-UP | 9.17 mg/dl | Standard Error 0.24 |
| Group 3 | Total Serum Calcium | 11P DAY 1 | 9.67 mg/dl | Standard Error 0.2 |
| Group 3 | Total Serum Calcium | 11P DAY 5 | 9.80 mg/dl | Standard Error 0.2 |
| Group 3 | Total Serum Calcium | 7A DAY 8 | 11.17 mg/dl | Standard Error 0.35 |
| Group 3 | Total Serum Calcium | baseline | 9.2 mg/dl | Standard Error 0.25 |
| Group 3 | Total Serum Calcium | 7A DAY 6 | 10.53 mg/dl | Standard Error 0.22 |
| Group 3 | Total Serum Calcium | 11P DAY 7 | 10.73 mg/dl | Standard Error 0.5 |
| Group 3 | Total Serum Calcium | 11P DAY 3 | 9.93 mg/dl | Standard Error 0.38 |
| Group 3 | Total Serum Calcium | 3P DAY 7 | 10.70 mg/dl | Standard Error 0.46 |
| Group 3 | Total Serum Calcium | 7A DAY 4 | 10.3 mg/dl | Standard Error 0.23 |
| Group 3 | Total Serum Calcium | 3P DAY 3 | 10.67 mg/dl | Standard Error 0.27 |
| Group 3 | Total Serum Calcium | 3P DAY 6 | 10.83 mg/dl | Standard Error 0.27 |
| Group 3 | Total Serum Calcium | 3P DAY 4 | 10.33 mg/dl | Standard Error 0.34 |
| Group 3 | Total Serum Calcium | 7A DAY 3 | 10.73 mg/dl | Standard Error 0.57 |
| Group 3 | Total Serum Calcium | 7A DAY 2 | 10.17 mg/dl | Standard Error 0.2 |
| Group 3 | Total Serum Calcium | 11P DAY 4 | 10.00 mg/dl | Standard Error 0.15 |
1,25 Vitamin D
pg/ml
Time frame: Baseline and Daily through day 8 then at follow-up visit
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | 1,25 Vitamin D | Day 4 | 32.23 pg/ml | Standard Error 2.32 |
| Group 1 | 1,25 Vitamin D | baseline | 34.13 pg/ml | Standard Error 3.03 |
| Group 1 | 1,25 Vitamin D | Day 6 | 42.77 pg/ml | Standard Error 4.23 |
| Group 1 | 1,25 Vitamin D | Day 5 | 32.27 pg/ml | Standard Error 1.8 |
| Group 1 | 1,25 Vitamin D | follow-up | 40.10 pg/ml | Standard Error 4.01 |
| Group 1 | 1,25 Vitamin D | Day 8 | 32.37 pg/ml | Standard Error 3.17 |
| Group 1 | 1,25 Vitamin D | Day 3 | 30.13 pg/ml | Standard Error 4.57 |
| Group 1 | 1,25 Vitamin D | Day 2 | 38.40 pg/ml | Standard Error 5.12 |
| Group 1 | 1,25 Vitamin D | Day 7 | 40.53 pg/ml | Standard Error 4.38 |
| Group 2 | 1,25 Vitamin D | Day 8 | 33.43 pg/ml | Standard Error 3.13 |
| Group 2 | 1,25 Vitamin D | baseline | 45.08 pg/ml | Standard Error 4.24 |
| Group 2 | 1,25 Vitamin D | Day 2 | 45.88 pg/ml | Standard Error 1.53 |
| Group 2 | 1,25 Vitamin D | Day 3 | 36.58 pg/ml | Standard Error 4.17 |
| Group 2 | 1,25 Vitamin D | Day 4 | 40.38 pg/ml | Standard Error 4.18 |
| Group 2 | 1,25 Vitamin D | follow-up | 45.78 pg/ml | Standard Error 4.72 |
| Group 2 | 1,25 Vitamin D | Day 5 | 46.40 pg/ml | Standard Error 6.12 |
| Group 2 | 1,25 Vitamin D | Day 6 | 34.90 pg/ml | Standard Error 4.91 |
| Group 2 | 1,25 Vitamin D | Day 7 | 37.12 pg/ml | Standard Error 3.58 |
| Group 3 | 1,25 Vitamin D | Day 5 | 32.07 pg/ml | Standard Error 3.79 |
| Group 3 | 1,25 Vitamin D | Day 4 | 35.17 pg/ml | Standard Error 2.63 |
| Group 3 | 1,25 Vitamin D | Day 2 | 39.77 pg/ml | Standard Error 2.69 |
| Group 3 | 1,25 Vitamin D | Day 6 | 35.37 pg/ml | Standard Error 2.98 |
| Group 3 | 1,25 Vitamin D | Day 3 | 36.73 pg/ml | Standard Error 2.75 |
| Group 3 | 1,25 Vitamin D | Day 8 | 30.63 pg/ml | Standard Error 4.79 |
| Group 3 | 1,25 Vitamin D | baseline | 39.0 pg/ml | Standard Error 4.09 |
| Group 3 | 1,25 Vitamin D | follow-up | 36.33 pg/ml | Standard Error 2.11 |
| Group 3 | 1,25 Vitamin D | Day 7 | 31.17 pg/ml | Standard Error 6.84 |
24 Hour Urine Calcium
mg/gm creatinine collected on day 7 of PTHrP infusion
Time frame: 24 hours
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Group 1 | 24 Hour Urine Calcium | 121.64 mg/gm creatinine | Standard Error 9.87 |
| Group 2 | 24 Hour Urine Calcium | 283.43 mg/gm creatinine | Standard Error 30.93 |
| Group 3 | 24 Hour Urine Calcium | 320.23 mg/gm creatinine | Standard Error 41.32 |
Amino-terminal Peptides of Procollagen 1 (P1NP)
% change from baseline
Time frame: Baseline, Daily, and 1 week follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 6 | -8.42 % change | Standard Error 5.07 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 8 | -16.03 % change | Standard Error 5.03 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 7 | -12.59 % change | Standard Error 6.17 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 2 | -1.05 % change | Standard Error 4.95 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | follow-up | -7.12 % change | Standard Error 2.29 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 3 | -6.83 % change | Standard Error 2.78 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | baseline | 0.00 % change | Standard Error 0 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 4 | -12.16 % change | Standard Error 0.57 |
| Group 1 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 5 | -5.63 % change | Standard Error 2.27 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 2 | -17.49 % change | Standard Error 5.93 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 6 | -31.71 % change | Standard Error 7.5 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 8 | -36.60 % change | Standard Error 9.64 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | baseline | 0.00 % change | Standard Error 0 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 7 | -30.98 % change | Standard Error 8.87 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 3 | -30.44 % change | Standard Error 7.1 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 4 | -25.66 % change | Standard Error 9.55 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | follow-up | 0.60 % change | Standard Error 9.58 |
| Group 2 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 5 | -21.27 % change | Standard Error 8.01 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | follow-up | 46.67 % change | Standard Error 17.34 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 5 | -45.04 % change | Standard Error 3.07 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 7 | -39.88 % change | Standard Error 2.78 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | baseline | 0.00 % change | Standard Error 0 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 2 | -23.88 % change | Standard Error 6.05 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 3 | -37.77 % change | Standard Error 6.56 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 4 | -39.44 % change | Standard Error 4.46 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 6 | -39.55 % change | Standard Error 1.75 |
| Group 3 | Amino-terminal Peptides of Procollagen 1 (P1NP) | Day 8 | -38.53 % change | Standard Error 3.4 |
Bone Specific Alkaline Phosphatase (BSAP)
% change from baseline
Time frame: Baseline, Daily, and 1 week follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 4 | -5.82 % change | Standard Error 1.58 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | follow-up | -1.25 % change | Standard Error 2.7 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 6 | -8.16 % change | Standard Error 9.32 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 5 | -0.33 % change | Standard Error 0.33 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | baseline | 0.00 % change | Standard Error 0 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 8 | -7.80 % change | Standard Error 8.66 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 3 | -6.35 % change | Standard Error 4.84 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 2 | -12.53 % change | Standard Error 8.6 |
| Group 1 | Bone Specific Alkaline Phosphatase (BSAP) | Day 7 | -11.91 % change | Standard Error 10.38 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 5 | -9.64 % change | Standard Error 4.73 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | baseline | 0.00 % change | Standard Error 0 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 2 | -1.17 % change | Standard Error 4.1 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 3 | -1.44 % change | Standard Error 3.07 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 4 | -3.79 % change | Standard Error 4.65 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 6 | -10.88 % change | Standard Error 4.04 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 7 | -16.78 % change | Standard Error 2.58 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | Day 8 | -14.01 % change | Standard Error 3.72 |
| Group 2 | Bone Specific Alkaline Phosphatase (BSAP) | follow-up | 6.16 % change | Standard Error 3.81 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 3 | 34.77 % change | Standard Error 6.53 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | baseline | 0.00 % change | Standard Error 0 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 7 | 9.86 % change | Standard Error 4.01 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 2 | 24.54 % change | Standard Error 7.01 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | follow-up | 18.23 % change | Standard Error 2.22 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 5 | 13.61 % change | Standard Error 9.76 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 4 | 19.49 % change | Standard Error 8.23 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 8 | 15.27 % change | Standard Error 11.63 |
| Group 3 | Bone Specific Alkaline Phosphatase (BSAP) | Day 6 | 9.02 % change | Standard Error 8.94 |
Fractional Excretion of Calcium
% calculated from daily second morning void
Time frame: daily
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Fractional Excretion of Calcium | Day 2 | 1.31 % of filtered load | Standard Error 0.59 |
| Group 1 | Fractional Excretion of Calcium | Day 5 | 3.05 % of filtered load | Standard Error 0.7 |
| Group 1 | Fractional Excretion of Calcium | Day 4 | 1.57 % of filtered load | Standard Error 0.25 |
| Group 1 | Fractional Excretion of Calcium | Baseline | 1.93 % of filtered load | Standard Error 0.91 |
| Group 1 | Fractional Excretion of Calcium | Day 7 | 2.72 % of filtered load | Standard Error 0.28 |
| Group 1 | Fractional Excretion of Calcium | Day 6 | 3.37 % of filtered load | Standard Error 0.67 |
| Group 1 | Fractional Excretion of Calcium | Day 3 | 1.07 % of filtered load | Standard Error 0.51 |
| Group 2 | Fractional Excretion of Calcium | Day 4 | 2.79 % of filtered load | Standard Error 0.76 |
| Group 2 | Fractional Excretion of Calcium | Baseline | 2.57 % of filtered load | Standard Error 0.73 |
| Group 2 | Fractional Excretion of Calcium | Day 2 | 2.26 % of filtered load | Standard Error 0.46 |
| Group 2 | Fractional Excretion of Calcium | Day 3 | 2.85 % of filtered load | Standard Error 0.61 |
| Group 2 | Fractional Excretion of Calcium | Day 5 | 2.05 % of filtered load | Standard Error 0.46 |
| Group 2 | Fractional Excretion of Calcium | Day 6 | 2.75 % of filtered load | Standard Error 0.25 |
| Group 2 | Fractional Excretion of Calcium | Day 7 | 3.94 % of filtered load | Standard Error 0.38 |
| Group 3 | Fractional Excretion of Calcium | Day 5 | 3.12 % of filtered load | Standard Error 0.46 |
| Group 3 | Fractional Excretion of Calcium | Day 2 | 4.11 % of filtered load | Standard Error 2.42 |
| Group 3 | Fractional Excretion of Calcium | Day 7 | 4.13 % of filtered load | Standard Error 0.73 |
| Group 3 | Fractional Excretion of Calcium | Day 6 | 5.42 % of filtered load | Standard Error 2.23 |
| Group 3 | Fractional Excretion of Calcium | Day 4 | 2.14 % of filtered load | Standard Error 0.4 |
| Group 3 | Fractional Excretion of Calcium | Day 3 | 3.27 % of filtered load | Standard Error 0.45 |
| Group 3 | Fractional Excretion of Calcium | Baseline | 2.38 % of filtered load | Standard Error 0.59 |
Parathyroid Hormone (1-84)
pg/ml
Time frame: Baseline and Daily
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Parathyroid Hormone (1-84) | Day 7 | 19.40 pg/ml | Standard Error 4.03 |
| Group 1 | Parathyroid Hormone (1-84) | Day 5 | 22.37 pg/ml | Standard Error 5.1 |
| Group 1 | Parathyroid Hormone (1-84) | Day 8 | 12.60 pg/ml | Standard Error 3.58 |
| Group 1 | Parathyroid Hormone (1-84) | baseline | 42.97 pg/ml | Standard Error 2.86 |
| Group 1 | Parathyroid Hormone (1-84) | follow-up | 56.37 pg/ml | Standard Error 5.18 |
| Group 1 | Parathyroid Hormone (1-84) | Day 4 | 26.77 pg/ml | Standard Error 3.24 |
| Group 1 | Parathyroid Hormone (1-84) | Day 2 | 23.47 pg/ml | Standard Error 1.48 |
| Group 1 | Parathyroid Hormone (1-84) | Day 3 | 21.43 pg/ml | Standard Error 3.65 |
| Group 1 | Parathyroid Hormone (1-84) | Day 6 | 21.13 pg/ml | Standard Error 5.88 |
| Group 2 | Parathyroid Hormone (1-84) | baseline | 30.70 pg/ml | Standard Error 5.56 |
| Group 2 | Parathyroid Hormone (1-84) | Day 7 | 5.67 pg/ml | Standard Error 1.2 |
| Group 2 | Parathyroid Hormone (1-84) | Day 3 | 5.23 pg/ml | Standard Error 1.75 |
| Group 2 | Parathyroid Hormone (1-84) | Day 5 | 7.54 pg/ml | Standard Error 1.8 |
| Group 2 | Parathyroid Hormone (1-84) | Day 8 | 3.00 pg/ml | Standard Error 0 |
| Group 2 | Parathyroid Hormone (1-84) | Day 2 | 7.82 pg/ml | Standard Error 1.5 |
| Group 2 | Parathyroid Hormone (1-84) | Day 4 | 7.88 pg/ml | Standard Error 3.21 |
| Group 2 | Parathyroid Hormone (1-84) | follow-up | 31.60 pg/ml | Standard Error 2.63 |
| Group 2 | Parathyroid Hormone (1-84) | Day 6 | 6.57 pg/ml | Standard Error 2.24 |
| Group 3 | Parathyroid Hormone (1-84) | follow-up | 44.20 pg/ml | Standard Error 10.87 |
| Group 3 | Parathyroid Hormone (1-84) | Day 6 | 3.00 pg/ml | Standard Error 0 |
| Group 3 | Parathyroid Hormone (1-84) | Day 3 | 3.00 pg/ml | Standard Error 0 |
| Group 3 | Parathyroid Hormone (1-84) | Day 4 | 3.00 pg/ml | Standard Error 0 |
| Group 3 | Parathyroid Hormone (1-84) | baseline | 48.27 pg/ml | Standard Error 15.93 |
| Group 3 | Parathyroid Hormone (1-84) | Day 2 | 3.60 pg/ml | Standard Error 0.5 |
| Group 3 | Parathyroid Hormone (1-84) | Day 5 | 3.00 pg/ml | Standard Error 0 |
| Group 3 | Parathyroid Hormone (1-84) | Day 7 | 3.00 pg/ml | Standard Error 0 |
| Group 3 | Parathyroid Hormone (1-84) | Day 8 | 3.00 pg/ml | Standard Error 0 |
Serum Amino-terminal Telopeptide of Collagen -1 (sNTX)
% change from baseline
Time frame: Baseline, Daily, and 1 week follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 2 | 32.86 % change | Standard Error 23.41 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 5 | 41.29 % change | Standard Error 20.06 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 7 | 35.04 % change | Standard Error 21.44 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 4 | 28.32 % change | Standard Error 20.26 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 8 | 65.77 % change | Standard Error 30.43 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 3 | 26.73 % change | Standard Error 23.19 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 6 | 11.41 % change | Standard Error 12.63 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | follow-up | -14.95 % change | Standard Error 2.97 |
| Group 1 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 6 | 123.08 % change | Standard Error 28.62 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 5 | 82.36 % change | Standard Error 20.62 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 3 | 91.53 % change | Standard Error 28.94 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 7 | 161.55 % change | Standard Error 41.54 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | follow-up | -3.33 % change | Standard Error 6.68 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 4 | 90.86 % change | Standard Error 32.25 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 8 | 214.90 % change | Standard Error 59.26 |
| Group 2 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 2 | 87.75 % change | Standard Error 18.79 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 8 | 108.69 % change | Standard Error 34.29 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 3 | 88.51 % change | Standard Error 19.99 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 4 | 89.57 % change | Standard Error 20.22 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 5 | 116.58 % change | Standard Error 13.85 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | follow-up | -9.02 % change | Standard Error 7.19 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 2 | 54.21 % change | Standard Error 10.64 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 6 | 150.82 % change | Standard Error 48.26 |
| Group 3 | Serum Amino-terminal Telopeptide of Collagen -1 (sNTX) | Day 7 | 176.42 % change | Standard Error 50.08 |
Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX)
% change from baseline
Time frame: Baseline, Daily, and 1 week follow-up
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 4 | 71.19 % change | Standard Error 18.88 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | follow-up | -35.73 % change | Standard Error 11.53 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 6 | 74.09 % change | Standard Error 26.72 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 5 | 79.39 % change | Standard Error 23.89 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 8 | 110.61 % change | Standard Error 30.92 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 3 | 66.67 % change | Standard Error 32.24 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 2 | 59.78 % change | Standard Error 18.14 |
| Group 1 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 7 | 109.27 % change | Standard Error 29.39 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 5 | 167.27 % change | Standard Error 25.3 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 2 | 147.12 % change | Standard Error 40.72 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 3 | 180.27 % change | Standard Error 44.45 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 4 | 167.01 % change | Standard Error 47.01 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 6 | 239.51 % change | Standard Error 49.42 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 7 | 283.15 % change | Standard Error 65.65 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 8 | 368.31 % change | Standard Error 93.63 |
| Group 2 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | follow-up | -8.60 % change | Standard Error 11.15 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 3 | 148.45 % change | Standard Error 36.8 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | baseline | 0.00 % change | Standard Error 0 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 7 | 267.89 % change | Standard Error 104.52 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 2 | 105.06 % change | Standard Error 11.54 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | follow-up | -41.33 % change | Standard Error 20.38 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 5 | 174.58 % change | Standard Error 47.26 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 4 | 165.16 % change | Standard Error 40.29 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 8 | 140.58 % change | Standard Error 78.58 |
| Group 3 | Serum Carboxy-terminal Telopeptide of Collagen -1 (sCTX) | Day 6 | 230.42 % change | Standard Error 54.1 |
Tubular Maximum of Phosphorous (TmP/GFR)
mg/dl calculated from daily second morning void
Time frame: daily
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 2 | 4.48 mg/dl | Standard Error 0.2 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 3 | 4.28 mg/dl | Standard Error 0.3 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 5 | 4.43 mg/dl | Standard Error 0.02 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 4 | 4.42 mg/dl | Standard Error 0.31 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Baseline | 3.43 mg/dl | Standard Error 0.26 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 7 | 4.15 mg/dl | Standard Error 0.08 |
| Group 1 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 6 | 4.90 mg/dl | Standard Error 0.08 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 2 | 4.08 mg/dl | Standard Error 0.23 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Baseline | 3.91 mg/dl | Standard Error 0.23 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 3 | 3.74 mg/dl | Standard Error 0.26 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 5 | 3.95 mg/dl | Standard Error 0.34 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 6 | 3.98 mg/dl | Standard Error 0.11 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 7 | 3.98 mg/dl | Standard Error 0.19 |
| Group 2 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 4 | 3.75 mg/dl | Standard Error 0.31 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Baseline | 3.38 mg/dl | Standard Error 0.35 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 7 | 2.95 mg/dl | Standard Error 0.28 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 2 | 3.47 mg/dl | Standard Error 0.46 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 6 | 3.38 mg/dl | Standard Error 0.35 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 3 | 3.25 mg/dl | Standard Error 0.5 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 4 | 3.15 mg/dl | Standard Error 0.45 |
| Group 3 | Tubular Maximum of Phosphorous (TmP/GFR) | Day 5 | 3.37 mg/dl | Standard Error 0.45 |